Issue 87, 2020

Designing inhalable metal organic frameworks for pulmonary tuberculosis treatment and theragnostics via spray drying

Abstract

Inhalable metal organic framework (MOF) aerosols have been developed via spray drying as a therapy for multi-drug resistant (MDR) tuberculosis (TB). The CuPOA2 (pyrazinoate acid) MOFs can be tailored to exhibit a respirable mass median aerodynamic diameter (MMAD) of 2.6 μm. This method is repeated to manufacture Gd0.1Cu0.9(POA)2 MOFs for inhalable theragnostics.

Graphical abstract: Designing inhalable metal organic frameworks for pulmonary tuberculosis treatment and theragnostics via spray drying

Supplementary files

Article information

Article type
Communication
Submitted
11 Aug 2020
Accepted
28 Sep 2020
First published
29 Sep 2020

Chem. Commun., 2020,56, 13339-13342

Designing inhalable metal organic frameworks for pulmonary tuberculosis treatment and theragnostics via spray drying

I. Luz, I. E. Stewart, N. P. Mortensen and A. J. Hickey, Chem. Commun., 2020, 56, 13339 DOI: 10.1039/D0CC05471B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements